相关实验视频

Updated: Jan 14, 2026

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies

Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies

Published on: April 5, 2024

脂肪组织重塑中的免疫代谢交叉:机制和治疗前景

Yeonho Son¹, Cheoljun Choi¹, Junhyuck Lee¹

¹College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.

Journal of obesity & metabolic syndrome

|October 27, 2025

概括

免疫细胞和脂肪细胞动态相互作用,影响能量平衡和代谢健康. 了解这种交叉通话是开发肥胖和代谢障碍新疗法的关键.

科学领域:

免疫代谢过程中的免疫代谢.
脂肪组织生物学脂肪组织生物学
细胞异质性细胞异质性

背景情况:

脂肪组织是一个关键的免疫代谢器官.
免疫细胞-脂肪细胞相互作用对于代谢调节至关重要.
这些相互作用的破坏有助于肥胖和代谢疾病.

研究的目的:

审查当前对脂肪组织免疫格局的理解.
突出不同免疫细胞子集的作用.
探索免疫细胞-脂肪细胞交叉通话的机制.

主要方法:

全球和单细胞转录基因分析.
空间配置文件的形成
谱系追踪谱系追踪谱系追踪谱系追踪

主要成果:

脂肪组织中免疫细胞种群的特征.
免疫细胞对脂肪细胞功能的影响机制 (周转,脂质处理,热生成).
来自脂肪细胞 (细胞因子,脂质媒介,细胞外囊泡,营养物质交换) 的相互信号.

结论:

免疫细胞和脂肪细胞之间的双向交叉声驱动脂肪组织重塑.
这种相互作用决定了代谢平衡或功能障碍.
洞察力可能会导致对肥胖和代谢疾病的新疗法目标.

关键词:

脂肪细胞是一种脂肪细胞.脂肪组织的脂肪组织.炎症炎症是一种炎症.巨细胞是一个巨细胞.肥胖问题肥胖问题

更多相关视频

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

相关概念视频

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...